Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Protease-inhibitory cephams and cephems and their use patented by Pliva

Sep. 13, 1999

Phthalazinones synthesized at Byk Gulden specifically inhibit PDE4

Sep. 10, 1999

Agents for allergic diseases in development by Dainippon Ink & Chemicals

Sep. 10, 1999

German collaboration yields new inhibitors of human tryptase

Sep. 7, 1999

Glaxo Wellcome patents improved adenosine A2A receptor agonists as antiinflammatory agents

Sep. 6, 1999

HMR and Sepracor resolve issues relating to fexofenadine

Sep. 3, 1999

New phenylethanolamine bronchodilators synthesized at Chinese university

Sep. 2, 1999

International patent covers Darwin Discovery's new PDE4/TNF inhibitors

Sep. 2, 1999

LeukoSite, Kyowa Hakko collaborate on the study of chemokine receptor antagonists

Aug. 30, 1999

Structural Bioinformatics receives SBIR grant for asthma treatment

Aug. 26, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
Anle-138b reduces mHTT aggregation, improves pathological phenotypes in Huntington’s models
BioWorld Science
Anle-138b (emrusolmin) is a diphenylpyrazole compound that directly interacts with oligomeric species of disease-related aggregating proteins, reducing aggregate...